IndraLab
Statements
ANGPTL4 inhibits angiogenesis. 10 / 27
|
1
1
21
2
reach
"However, several studies have claimed that ANGPTL4 inhibits vascular angiogenesis and prevents tumor metastasis in melanoma B16F0, lung cancer 3LL [XREF_BIBR] and colon cancer CMT93 [XREF_BIBR] xenograft mouse models; however, contrasting results were observed in breast cancer [XREF_BIBR], renal cell carcinoma [XREF_BIBR], and ovarian cancer [XREF_BIBR, XREF_BIBR] xenograft models, indicating that ANGPTL4 may act as a tissue specific and multifunctional vascular modulator."
reach
"Various studies have also shown that ANGPTL4 expression prevents metastasis and angiogenesis by reducing vascular leakiness, cell motility and invasiveness in different neoplasm types, including melanoma, gastric, lung and colorectal tumors, as well as metastases [XREF_BIBR - XREF_BIBR]."
| PMC
reach
"Collectively, these observations support a possible role for ANGPTL4 in the promotion of metastasis in UM and provide a foundation for future studies to determine whether combined inhibition of both ANGPTL4 and VEGF could simultaneously target tumor induced angiogenesis and metastasis, and thereby provide more effective therapies for patients with primary and metastatic UM."
reach
"It has been reported that the C-terminal domain of ANGPTL4 protein inhibits vascular epithelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)-mediated angiogenesis [XREF_BIBR], and SNP rs1044250 is capable of altering the activity of ANGPTL4 C-terminus, therefore, the SNP rs1044250 may lead to a decreased angiogenesis and dysfunctional endothelial repairment."